Are peptides clinically studied to improve skin?

Multiple peer-reviewed studies confirm that specific peptides and active ingredients improve measurable skin parameters. Copper peptide GHK-Cu is one of the most-studied peptides in skin science, with over 50 published studies. Acetyl Hexapeptide-8 delivered up to 48.9% overall anti-wrinkle efficacy versus placebo in a randomized clinical study (Wang 2013). Matrixyl 3000 supports the appearance of firmer skin, with collagen findings in laboratory (in-vitro) tests. PDRN is valued for a firmer, more revitalised-looking complexion. Glutathione supports a brighter, more even-looking skin tone and antioxidant defence.

What concentrations does Skingenetix use?

Skingenetix discloses exact concentrations on every product. Each active ingredient is dosed at or above the concentration shown to be effective in published clinical trials.

The Science Behind Skingenetix Peptide Skincare

Q: What types of studies does Skingenetix reference?

Skingenetix references peer-reviewed clinical studies published in dermatology and cosmetic science journals. All cited studies are publicly accessible via PubMed. We do not reference in-house consumer perception surveys or unverified supplier claims.

Conical flask and beaker of blue solution on a dark laboratory bench beside a microscope with petri dishes, representing the peptide research behind Skingenetix formulas

Scientific Research

The Research Behind Our Formulas

Every ingredient in Skingenetix is supported by peer-reviewed studies published in dermatology and cosmetic science journals. All referenced research is publicly accessible.

Our Evidence Standard

Peer-Reviewed Only

We reference studies published in scientific journals with independent peer review. No in-house surveys or unverified supplier claims.

Publicly Accessible

Every study we cite is available on PubMed. We link directly to the source so you can verify our claims yourself.

Clinically Relevant Doses

We formulate at concentrations proven effective in clinical trials. If a study uses 10%, we use 10%. No under-dosing.

Clinically Studied Active Ingredients

Each ingredient is selected based on published peer-reviewed research

Copper Peptide GHK-Cu

Supports the appearance of firmer, smoother skin. One of the most-studied peptides in skin science, with over 50 published studies.

View Copper Peptide Research

Acetyl Hexapeptide-8

Helps visibly relax the look of expression lines. In a randomized trial, 48.9% overall anti-wrinkle efficacy versus placebo (Wang 2013).

View Acetyl Hexapeptide-8 Research

Matrixyl 3000

A dual matrikine-peptide duo associated with the skin's natural collagen activity, for firmer, smoother-looking skin. Supported by collagen findings in laboratory (in-vitro) tests.

View Matrixyl 3000 Research

PDRN

Salmon-derived polynucleotides (INCI: Sodium DNA) valued for a firmer, smoother and more revitalised-looking complexion.

View PDRN Research

Glutathione

The body's master antioxidant. Helps neutralise free radicals and supports a brighter, more even-looking skin tone and radiance.

View Glutathione Research

Gloved hands pipetting into a microplate at a dark laboratory bench beside a microscope, illustrating independent peer-reviewed peptide research

How We Work

Our Transparency Commitment

We do not commission our own clinical studies. All research we reference is independent, peer-reviewed, and publicly accessible via PubMed or scientific journal databases.

Topical peptide delivery remains an active area of research. We reference studies conducted at cosmetically relevant concentrations and clearly distinguish between laboratory (in-vitro) conditions and human trials (in-vivo).

Frequently Asked Questions

What types of studies does Skingenetix reference?

We reference peer-reviewed clinical studies published in dermatology and cosmetic science journals such as the International Journal of Cosmetic Science, BioMed Research International, and the International Journal of Molecular Sciences. All cited studies are publicly accessible via PubMed. We do not count in-house consumer perception surveys or unverified ingredient supplier marketing claims as evidence.

Are these results guaranteed for every person?

Individual results vary based on skin type, age, existing skin condition, and consistency of use. The clinical studies we reference show statistically significant results across study populations, but no skincare product can guarantee identical results for every individual. We present the research transparently so you can make an informed decision.

Where can I read the full studies?

Every study referenced on our research pages includes a direct link to the publication on PubMed or the relevant journal website. Links open in a new tab. PubMed is a free, publicly accessible database maintained by the U.S. National Library of Medicine containing over 36 million biomedical citations.

Why do you disclose exact ingredient concentrations?

Because concentration determines whether an ingredient is effective or cosmetic decoration. A peptide at 0.01% may appear on an ingredient list but deliver no measurable benefit. We publish exact percentages so you can compare our formulations directly against the concentrations used in published clinical trials.

How do the peptides in Skingenetix work together?

Each active ingredient in our formulations supports the skin in a different way. GHK-Cu supports the appearance of firmness and elasticity. Matrixyl 3000 uses matrikine peptide signals associated with the skin's collagen activity. Acetyl Hexapeptide-8 helps visibly relax the look of expression lines. PDRN supports a firmer, more revitalised-looking complexion. Glutathione acts as a powerful antioxidant, helping neutralise free radicals and supporting a brighter, more even-looking skin tone. Together, this multi-active approach targets the visible signs of aging from several angles at once.